2023-11-07 08:36:07 ET
- Losers: Ventyx Biosciences ( VTYX ) -76% announces results from the phase 2 trial of VTX958 in patients with moderate to severe plaque Psoriasis and provides corporate update.
- Alto Ingredients ( ALTO ) -50% reports third quarter 2023 results .
- Coherus Biosciences ( CHRS ) -22% after Q3 earning release .
- Aura Biosciences ( AURA ) -20% announces proposed public offering of common stock.
- Clover Health Investments Corp ( CLOV ) -12% reports Q3 results .
- MSP Recovery ( LIFW ) -14% .
- Alpine Immune Sciences ( ALPN ) -12% proposes $150M offering .
- Kaixin Auto Holdings ( KXIN ) -11% .
- Sanmina Corp ( SANM ) -11% after Q4 earning release .
- B. Riley Financial ( RILY ) -11% .
- CNH Industrial ( CNHI ) -10% after Q3 earning release .
- Crescent Point Energy Corp ( CPG ) -7% announces CDN$500 Million bought deal offering of common shares .
- EHang Holdings Ltd ( EH ) -7% .
- Werewolf Therapeutics ( HOWL ) -7% .
- RumbleON ( RMBL ) -7% after Q3 earning release .
- Velo3D ( VLD ) -6% after Q3 earning release .
- Tenon Medical ( TNON ) -5% .
- Kodiak Sciences ( KOD ) -5% .
- AngloGold Ashanti ( AU ) -5% .
For further details see:
EH, HOWL and TNON among pre-market losers